4L02 | Crystal Structure of SphK1 with inhibitor | date | 2013-05-30 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Min, X., Walker, N., Wang, Z. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.75 | ||||||||||||
ligand | 1V2 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure guided design of a series of sphingosine kinase (SphK) inhibitors., Gustin DJ, Li Y, Brown ML, Min X, Schmitt MJ, Wanska M, Wang X, Connors R, Johnstone S, Cardozo M, Cheng AC, Jeffries S, Franks B, Li S, Shen S, Wong M, Wesche H, Xu G, Carlson TJ, Plant M, Morgenstern K, Rex K, Schmitt J, Coxon A, Walker N, Kayser F, Wang Z, Bioorg Med Chem Lett. 2013 Jun 20. pii: S0960-894X(13)00739-7. doi:, 10.1016/j.bmcl.2013.06.030. PMID:23845219 |
Data retrieval |
View 4L02 in 3D |
Visual 3D analysis of 4L02 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4L02 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |